The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genotyping upper gastrointestinal cancer in daily clinical care.
Thomas Zander
Consultant or Advisory Role - Amgen; Merck; Novartis; Roche
Research Funding - Novartis
Michael Kloth
No relevant relationships to disclose
Shahram Zoghi
No relevant relationships to disclose
Laura Groneck
No relevant relationships to disclose
Birgit Cremer
Research Funding - Novartis
Roland Schnell
No relevant relationships to disclose
Marcel Reiser
No relevant relationships to disclose
Jutta Benz
No relevant relationships to disclose
Tom Luedde
No relevant relationships to disclose
Achim Rothe
No relevant relationships to disclose
Yon-Dschun Ko
No relevant relationships to disclose
Andreas Draube
No relevant relationships to disclose
Stefan Paul Moenig
No relevant relationships to disclose
Juergen Wolf
Consultant or Advisory Role - Boehringer Ingelheim; Novartis; Pfizer; Roche
Arnulf H Hölscher
No relevant relationships to disclose
Reinhard Buettner
Consultant or Advisory Role - Novartis; Pfizer; Roche